SubHero Banner
Text

August 2018

Core topics in this month’s edition include:

  • Oxervate (cenegermin-bkbj) - new orphan drug approval
  • Onpattro (patisiran) - new orphan drug approval
  • Orkambi (lumacaftor/ivacaftor) - expanded indication, new formulation approval 
  • valsartan, valsartan/hydrochlorothiazide (HCTZ), and amlodipine/valsartan/HCTZ tablets - drug recall

Download PDF